[go: up one dir, main page]

WO2004009764A3 - Methods and compositions concerning altered yellow fever virus strains - Google Patents

Methods and compositions concerning altered yellow fever virus strains Download PDF

Info

Publication number
WO2004009764A3
WO2004009764A3 PCT/US2003/022001 US0322001W WO2004009764A3 WO 2004009764 A3 WO2004009764 A3 WO 2004009764A3 US 0322001 W US0322001 W US 0322001W WO 2004009764 A3 WO2004009764 A3 WO 2004009764A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
fever virus
yellow fever
altered
virus strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/022001
Other languages
French (fr)
Other versions
WO2004009764A2 (en
Inventor
Alan Barrett
Monica Mcarthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Priority to EP03765574A priority Critical patent/EP1546176A4/en
Priority to AU2003256532A priority patent/AU2003256532A1/en
Publication of WO2004009764A2 publication Critical patent/WO2004009764A2/en
Publication of WO2004009764A3 publication Critical patent/WO2004009764A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention concerns the use of methods and/or compositions for the improvement of the reversion frequency of an attenuated member of the Flaviviridae family. In particular embodiments of the invention, methods and compositions of the invention may be used for the improvement and/or production of a Yellow Fever virus vaccine.
PCT/US2003/022001 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains Ceased WO2004009764A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03765574A EP1546176A4 (en) 2002-07-19 2003-07-11 METHODS AND COMPOSITIONS ASSOCIATED WITH ALTERED YELLOW FEVER VIRUS STEM
AU2003256532A AU2003256532A1 (en) 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39744002P 2002-07-19 2002-07-19
US60/397,440 2002-07-19

Publications (2)

Publication Number Publication Date
WO2004009764A2 WO2004009764A2 (en) 2004-01-29
WO2004009764A3 true WO2004009764A3 (en) 2004-04-22

Family

ID=30771061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/022001 Ceased WO2004009764A2 (en) 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains

Country Status (3)

Country Link
EP (1) EP1546176A4 (en)
AU (1) AU2003256532A1 (en)
WO (1) WO2004009764A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3150404A1 (en) 2009-07-31 2011-02-03 Pnuvax Inc. High yield yellow fever virus strain with increased propagation in cells
AR079970A1 (en) * 2010-07-23 2012-02-29 Xcellerex Inc HIGH PERFORMANCE VIRUSES OF THE YELLOW FEVER VIRUS WITH INCREASED PROPAGATION IN THE CELLS
US9284356B2 (en) 2011-07-12 2016-03-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Identification of a west nile virus CD4 T cell epitope and use thereof
WO2013138670A1 (en) * 2012-03-15 2013-09-19 Icahn School Of Medicine At Mount Sinai Yellow fever virus ns5 mutants as flavivirus vaccine candidates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171854B1 (en) * 1997-04-11 2001-01-09 Fundaco Oswaldo Cruz-Fiocruz Yellow fever infectious cDNA and plasmids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2251036A1 (en) * 1997-02-28 2010-11-17 Sanofi Pasteur Biologics Co. Chimeric flavivirus vaccines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171854B1 (en) * 1997-04-11 2001-01-09 Fundaco Oswaldo Cruz-Fiocruz Yellow fever infectious cDNA and plasmids

Also Published As

Publication number Publication date
EP1546176A4 (en) 2006-01-11
WO2004009764A2 (en) 2004-01-29
AU2003256532A1 (en) 2004-02-09
EP1546176A2 (en) 2005-06-29
AU2003256532A8 (en) 2004-02-09

Similar Documents

Publication Publication Date Title
WO2005042767A3 (en) Compositions and methods for detecting severe acute respiratory syndrome coronavirus
SG156666A1 (en) Vaccines against japanese encephalitis virus and west nile virus
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
WO2007030810A3 (en) Multiparameter whole blood monitor and method
WO2007001406A3 (en) Aryl-containing macrocyclic compounds
WO2002009643A3 (en) Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
AU2002254343A1 (en) Halo-polymer nanocomposite compositions, methods, and products employing such compositions
WO2005032582A8 (en) Immunogenic compositions for streptococcus pyogenes
AU2002231961A1 (en) Detectable compositions, methods of forming the same and detection techniques
WO2005082020A3 (en) Flavivirus vaccines
WO2006076003A3 (en) Vaccinia virus strains
EP1570067A4 (en) METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST HIV VIRUSES
AU2002307971A1 (en) Vaccine against the nile fever virus
WO2004091524A3 (en) Respiratory virus vaccines
WO2002072803A3 (en) Subgenomic replicons of the flavivirus dengue
WO2006072348A3 (en) Alkinyl-substituted thiophenes
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
WO2004009764A3 (en) Methods and compositions concerning altered yellow fever virus strains
WO2004050613A3 (en) 2-substituted-3-propenamide derivatives and methods of using the same
WO2002028362A3 (en) Vaccine composition and stabilisation method
WO2008017870A8 (en) Attenuated polio viruses
WO2006029300A8 (en) Flavivirus variants having phenotypic variation and immunogenic compositions thereof
WO2007086898A3 (en) Methods and compositions related to anthrax spore glycoproteins
WO2005067906A3 (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
WO2004096121A3 (en) Compositions and methods for preventing infection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003765574

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003765574

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003765574

Country of ref document: EP